Should show an early cure rate of 100% I would view anything less than this as failure....of course with the NS5A inhibitors the final outcome SVR 12 is what really matters. Looking forward to seeing VRTX's comparable compounds data!!!
I really thought they would hit SVR 12 100% Genotype 2/3 was only ninety percent...really can't help but wonder how many of these patients will relapse....7977 relapse rate really makes me think that these numbers are going to drop!!!